- Home
- MTEN vs LSTA Comparison
MTEN vs LSTA Comparison
Compare MTEN & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- LSTA
- Stock Information
- Founded
- MTEN 2015
- LSTA 1980
- Country
- MTEN China
- LSTA United States
- Employees
- MTEN N/A
- LSTA N/A
- Industry
- MTEN Building Products
- LSTA Misc Health and Biotechnology Services
- Sector
- MTEN Industrials
- LSTA Health Care
- Exchange
- MTEN Nasdaq
- LSTA Nasdaq
- Market Cap
- MTEN 64.3M
- LSTA 22.5M
- IPO Year
- MTEN 2024
- LSTA N/A
- Fundamental
- Price
- MTEN $18.57
- LSTA $2.72
- Analyst Decision
- MTEN
- LSTA Strong Buy
- Analyst Count
- MTEN 0
- LSTA 1
- Target Price
- MTEN N/A
- LSTA $15.00
- AVG Volume (30 Days)
- MTEN 100.0K
- LSTA 23.5K
- Earning Date
- MTEN 04-30-2025
- LSTA 08-11-2025
- Dividend Yield
- MTEN N/A
- LSTA N/A
- EPS Growth
- MTEN N/A
- LSTA N/A
- EPS
- MTEN N/A
- LSTA N/A
- Revenue
- MTEN $10,120,257.00
- LSTA $1,000,000.00
- Revenue This Year
- MTEN N/A
- LSTA N/A
- Revenue Next Year
- MTEN N/A
- LSTA N/A
- P/E Ratio
- MTEN N/A
- LSTA N/A
- Revenue Growth
- MTEN 23.03
- LSTA N/A
- 52 Week Low
- MTEN $2.21
- LSTA $1.87
- 52 Week High
- MTEN $22.50
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- MTEN N/A
- LSTA 52.43
- Support Level
- MTEN N/A
- LSTA $2.34
- Resistance Level
- MTEN N/A
- LSTA $3.09
- Average True Range (ATR)
- MTEN 0.00
- LSTA 0.25
- MACD
- MTEN 0.00
- LSTA 0.01
- Stochastic Oscillator
- MTEN 0.00
- LSTA 50.67
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.